Dihexa 10 million times more potent than BDNF claim, is that actually meaningful or just marketing
Posted by student748 in Research & News - 12 points, 6 comments.
Was reading the nootropic god stack page here on researchsafe (/peptides/nootropic-god-stack) and the dihexa bit caught my eye. It says dihexa is a HGF/c-Met activator driving synapse formation, described as 10 million times more potent than BDNF at synapses. For what it is worth that number sets off alarm bells for me. Potency comparisons across totally different signalling pathways are a bit of a stretch to compare directly right? Like BDNF binds trkB receptors and dihexa works through HGF/c-Met, so saying one is X million times more potent than the other is comparing apples to oranges mechanistically.
I get that the preclinical data on dihexa looks interesting for cognitive stuff but i havent seen much in the way of human data and the half life listed is around 12h which seems long for something people describe as fast acting. Anyone here actually tried dihexa on its own rather than in a stack? Keen to hear whether the synaptogenesis claims translated to anything you actually noticed subjectively. The whole nootropic god stack combining four neurotrophic peptides at once seems like a lot to throw at your brain without knowing interactions. Chur for any input.
Comments
- fasted_scientist: Ngl that 10 million figure always makes me raise an eyebrow. Potency isn’t really transferable when you’re talking about different receptors and pathways – BDNF works through TrkB, dihexa via HGF/c‑Met, so comparing them head‑to‑head is more marketing maths than a real measure of effect. I haven’t tried dihexa solo yet, mostly because human data is thin and the 12‑hour half‑life feels at odds with the fast‑acting claims people toss around. Has anyone actually noticed a clear subjective boost, o
- nina489: The 12-hour half-life thing is a I had not thought about. If it really takes time to build up then the "fast-acting" claims people make are basically just impatience mixed with placebo, no? Have you seen any pharmacokinetic data that is actually from humans or is it all extrapolated from animal models? That is the part that worries me more than the potency marketing.
- sleep_coastal: Anecdotally I tried dihexa solo at low dose for a week and felt nothing noticeable beyond a mild headache so the 10 million claim feels like marketing fluff to me anyone else actually notice a clear cognitive bump?
- student748: Cheers for that, the headache thing is interesting, for what it is worth that seems like the kind of thing you'd get from HGF signalling going a bit haywire rather than a clean cognitive boost. A week at low dose though, did you subq or oral? Wondering if route matters heaps here given that 12h half life claim. Yeah nah the million times thing just feels like someone ran with a rodent hippocampal slice number and never looked back.
- student748: Yeah nah that is exactly my worry too, for what it is worth i could only find the half-life figure referenced from animal studies, nothing human that i could track down. So the 12h number might be rodent-derived and scaled, which is a pretty rough extrapolation for something acting on CNS targets. And if it is all preclinical PK then the fast-acting claims are even more suspect, like you said. Keen to hear if anyone here has seen actual human pharmacokinetic data anywhere, because i sure could n
- student748: Chur for confirming that, was starting to think i was just being overly skeptical. The marketing maths thing is exactly what bugs me about it. For what it is worth the half life mismatch is the part that really gets me, like if its genuinely 12h then the "felt it immediately" reports people give are probably just placebo or something else in their stack. Have you seen any animal data on actual cognitive outcomes rather than just the potency comparison? That would be more useful than the headlin
Community discussion - research and educational context only. Not medical advice.